These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 141117)

  • 1. Urine plasmin-like substances as an index of kidney allograft rejections.
    Fukao K; Kashiwagi N; Kajiwara T; Ishikawa M; Husberg B; Weil R; Starzl TE
    Transplantation; 1977 May; 23(5):407-13. PubMed ID: 141117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urine fibrin degradation products in detection and management of acute and chronic renal transplant rejection.
    Cattran DC; Hockley M; Fenton SS; Wilson DR
    Clin Nephrol; 1977 Jun; 7(6):255-61. PubMed ID: 326454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The determination of fibrinolytic degradation products in concentrated urine after renal transplantation.
    Ekberg M; Bergentz SE; Hedner U; Nilsson IM
    Scand J Urol Nephrol; 1976; 10(1):56-62. PubMed ID: 775625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of urinary fibrin-fibrinogen degradation products in kidney transplantation.
    Exaire E; Flores-Izquierdo G; Ortiz F; Pizzuto J; Cruz M; Gutiérrez ML
    Arch Invest Med (Mex); 1978; 9(3):503-10. PubMed ID: 361009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Urinary FDP D-dimer and E fragments in renal transplantation].
    Akiyama T; Ikegami M; Imanishi M; Ishii T; Nishioka T; Uemura T; Kunikata S; Mitsubayashi S; Kanda H; Matsuura T
    Nihon Hinyokika Gakkai Zasshi; 1990 Nov; 81(11):1680-5. PubMed ID: 2287115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A simple test for early detection of severe renal homograft rejection.
    Oppolzer R; Leithner C; Wolf A; Pinggera W; Stummvoll H
    Proc Eur Dial Transplant Assoc; 1975; 11():326-32. PubMed ID: 667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary fibrin degradation products--a three year comparative study.
    Schmitt E; Seyfarth M; Templin R; Schneider P; Klinkmann H
    Proc Eur Dial Transplant Assoc; 1978; 15():466-72. PubMed ID: 368788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical significance of fibrinuria with fibrinogen split-product E following kidney allotransplantation.
    Zühlke V; Hölscher M; Reichel W; Pernice G
    Contrib Nephrol; 1975; 1():103-8. PubMed ID: 797519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic value of urinary fibrin degradation products.
    Schmitt E; Seyfarth M; Templin R; Schneider P; Klinkmann H
    Nephron; 1980; 25(1):25-9. PubMed ID: 6986037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specific identification of urinary fibrinogen, fibrinogen degradation products, and cross-linked fibrin degradation products in renal diseases and after renal allotransplantation.
    Scott WL; Francis CW; Knutson DW; Marder VJ
    J Lab Clin Med; 1986 Jun; 107(6):534-43. PubMed ID: 3519810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Fibrin degradation products (FDP) in the urine after kidney transplantation].
    Malý J; Pecka M; Erben J; Radochová D; Bláha M; Vanásek J; Siroký O; Zahradník J
    Vnitr Lek; 1983 Jul; 29(6):598-603. PubMed ID: 6351421
    [No Abstract]   [Full Text] [Related]  

  • 12. Urinary excretion of NAG and FDP in acute renal graft rejection.
    Garcia B; Thompson AE; Tucker SM; Wing AJ
    Proc Eur Dial Transplant Assoc; 1975; 11():311-9. PubMed ID: 1105552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Minimum steriod requirements in renal transplant patients monitored by urinary fibrin degradation products and complement.
    Anderton JL; Fananapazir L; Eccleston M
    Proc Eur Dial Transplant Assoc; 1977; 14():342-50. PubMed ID: 341136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Diagnostic significance of the demonstration of fibrin and fibrinogen degradation products in the urine].
    Bendel M; Oetliker O; Montandon A; Beck EA
    Schweiz Med Wochenschr; 1975 Aug; 105(33):1040-7. PubMed ID: 1099647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determination of urinary fibrin/fibrinogen degradation products by radioimmunoassay.
    Ekberg M; Hedner U; Larsson I; Nilsson IM; Nosslin B
    Scand J Clin Lab Invest; 1976 Sep; 36(5):453-9. PubMed ID: 790536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sequential determinations of urinary cytology and plasma and urinary lymphokines in the management of renal allograft recipients.
    Simpson MA; Madras PN; Cornaby AJ; Etienne T; Dempsey RA; Clowes GH; Monaco AP
    Transplantation; 1989 Feb; 47(2):218-23. PubMed ID: 2645701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibrinolytic degradation products in urine of anticoagulated transplant patients.
    Aguilo JJ; Bowie EJ; Woods JE; Owen CA
    Eur Urol; 1978; 4(1):46-9. PubMed ID: 342250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Diagnostic value of determining urinary fibrin split products in glomerulonephritis, pyelonephritis and graft rejection].
    Schmitt E; Seyfarth M; Templin R; Schneider P; Klinkmann H
    Z Urol Nephrol; 1978 Nov; 71(11):787-97. PubMed ID: 366978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Studies of urinary proteins, FDP (fibrinogen degradation products), and NAG (N-acetyl-beta-D-glucosaminidase) in renal transplanted patients].
    Kunikata S; Ikegami M; Imanishi M; Nishioka T; Ishii T; Uemura T; Kanda H; Matsuura T; Akiyama T; Kurita T
    Hinyokika Kiyo; 1989 Aug; 35(8):1299-304. PubMed ID: 2816597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation of clinical outcomes after tacrolimus conversion for resistant kidney rejection or cyclosporine toxicity with pathologic staging by the Banff criteria.
    Morrissey PE; Gohh R; Shaffer D; Crosson A; Madras PN; Sahyoun AI; Monaco AP
    Transplantation; 1997 Mar; 63(6):845-8. PubMed ID: 9089224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.